|
Market Closed -
Nasdaq
16:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 18.58 USD | +2.65% |
|
+11.46% | +95.79% |
| 08-13 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
| Market Cap | 68.37M 60.69M 56.8M 51.48M 97.22M 6.59B 97.93M 682M 265M 3.36B 257M 251M 10.81B | P/E 2026 * |
0.8x | P/E 2027 * | -2.05x |
|---|---|---|---|---|---|
| Enterprise Value | 68.37M 60.69M 56.8M 51.48M 97.22M 6.59B 97.93M 682M 265M 3.36B 257M 251M 10.81B | EV / Sales 2026 * |
0.87x | EV / Sales 2027 * | 0.6x |
| Free-Float |
77.3% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FBIOP | Delayed | |
CBOE
| FBIOP | Real-time | |
|
Deutsche Boerse AG
| CNB0 | Delayed |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +2.65% | ||
| 1 week | +11.46% | ||
| Current month | +12.54% | ||
| 1 month | -0.91% | ||
| 3 months | -8.16% | ||
| 6 months | +36.42% | ||
| Current year | +95.79% |
| 1 week | 16.05 |  | 18.58 |
| 1 month | 16.04 | | 18.76 |
| Current year | 9.49 | | 21.43 |
| 1 year | 6.27 | | 21.43 |
| 3 years | 4.72 | | 21.43 |
| 5 years | 4.72 | | 26.6 |
| 10 years | 0 | | 26.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 2013-12-19 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 2012-02-21 |
David Jin
DFI | Director of Finance/CFO | 36 | 2022-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 2008-11-30 |
| Chairman | 71 | 2013-12-19 | |
J. Jay Lobell
BRD | Director/Board Member | 63 | 2006-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.65% | +11.46% | - | - | 69.7M | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,019B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 610B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 470B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 344B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 336B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 266B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 241B | |
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| Average | +0.60% | -3.71% | +26.44% | +56.59% | 409.2B | |
| Weighted average by Cap. | +0.05% | -3.43% | +29.52% | +67.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.79M 69.95M 65.46M 59.33M 112M 7.6B 113M 786M 306M 3.87B 296M 289M 12.46B | 113M 101M 94.08M 85.27M 161M 10.92B 162M 1.13B 439M 5.57B 425M 416M 17.9B |
| Net income | 88.25M 78.34M 73.31M 66.45M 125M 8.51B 126M 880M 342M 4.34B 331M 324M 13.95B | -37.81M -33.57M -31.41M -28.47M -53.77M -3.65B -54.16M -377M -147M -1.86B -142M -139M -5.98B |
| Net Debt | - | - |
Employees
78
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-06 | US$18.58 | +2.65% | 4,885 |
| 26-10-05 | US$18.10 | +7.35% | 30,165 |
| 26-10-02 | US$16.86 | +4.98% | 25,188 |
| 26-10-01 | US$16.06 | -2.73% | 7,287 |
| 26-09-30 | US$16.51 | -0.96% | 16,218 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.050USD
Average target price
5.000USD
Spread / Average Target
+143.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
Select your edition
All financial news and data tailored to specific country editions
